This study aims to systematically investigate the biological functions of SEC61G in NSCLC brain metastases, with a particular focus on its potential regulation of PGAM1 activity and metabolic reprogramming, as well as its impact on the tumor immune microenvironment. The gene discussed is PGAM1; the disease is neoplasm.